-
REAL-WORLD EFFECTIVENESS OF TEPOTINIB MONOTHERAPY (TEPOTINIB) VERSUS PEMBROLIZUMAB ± CHEMOTHERAPY (PEMBRO±CT) IN 1L FOR PATIENTS WITH MET EXON 14 SKIPPING ALTERATIONS IN LOCALLY ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER IN THE US
Aug 11, 2026, 17:16 PM -
A MULTI-COUNTRY PAYER AND HTA EXPERT SURVEY EXAMINING HOW ACCESS DECISION-MAKERS NAVIGATE INFORMATION OVERLOAD AND EVOLVING EVIDENCE SOURCES
Aug 11, 2026, 17:16 PM -
DOES INTERNATIONAL MIGRATION SHIFT HEALTHCARE SPENDING TOWARD FORMAL CARE? EVIDENCE FROM RURAL BANGLADESH
Aug 11, 2026, 17:16 PM -
DATA ACCESSIBILITY AND METHODOLOGICAL HETEROGENEITY IN ESTIMATING THE BURDEN OF RARE DISEASES ACROSS FOUR CENTRAL AND EASTERN EUROPEAN COUNTRIES: A CROSS-COUNTRY COMPARISON
Aug 11, 2026, 17:16 PM -
EXTERNAL VALIDATION OF DIABETIC RETINOPATHY RISK PREDICTION EQUATIONS IN TAIWANESE PATIENTS WITH TYPE 2 DIABETES
Aug 11, 2026, 17:16 PM -
FOREGONE HEALTH GAINS FROM PASKWIL-NEGATIVE ONCOLOGY DRUGS IN THE PALLIATIVE SETTING: A MODEL-BASED ANALYSIS
Aug 11, 2026, 17:16 PM -
FOUNDATIONS BEFORE INTEGRATION: STAKEHOLDER PRIORITIES FOR HTA DEVELOPMENT IN SLOVENIA IN THE ERA OF THE EU HTA REGULATION
Aug 11, 2026, 17:16 PM -
PROCUREMENT AND EXPENDITURE TRENDS OF ORPHAN AND NON-ORPHAN HIGH-COST MEDICINES DISPENSED THROUGH PUBLIC OUTPATIENT PHARMACIES IN GREECE, 2020-2025
Aug 11, 2026, 17:16 PM -
UNDERSTANDING EMPLOYMENT AND FINANCIAL CHALLENGES OF CARE PARTNERS OF PEOPLE WITH ALZHEIMER'S DISEASE AND OTHER DEMENTIAS: A MULTI-COUNTRY MIXED METHODS STUDY
Aug 11, 2026, 17:16 PM -
CONVERGENCE OR PLURALISM? TRACKING METHODOLOGICAL TRENDS IN EARLY EU JOINT CLINICAL ASSESSMENTS
Aug 11, 2026, 17:16 PM -
A STRUCTURED FRAMEWORK FOR CONFOUNDER IDENTIFICATION: A CAUSAL INFERENCE APPROACH FOR LOCALIZED OR LOCALLY ADVANCED HIGH-RISK PROSTATE CANCER
Aug 11, 2026, 17:16 PM -
UTILIZATION AND EXPENDITURE TRENDS OF MEDICINES DISPENSED THROUGH PUBLIC OUTPATIENT PHARMACIES IN GREECE: A COMPARISON OF SPECIAL ACCESS AND STANDARD PATHWAYS 2020-2025
Aug 11, 2026, 17:16 PM -
LOW-COST FEATURE EXTRACTION FROM CLINICAL NOTES USING HUMMINGBIRD: ECOG PERFORMANCE STATUS OF LUNG CANCER PATIENTS
Aug 11, 2026, 17:16 PM -
GEOGRAPHIC VARIATION IN HOW PHYSICIANS CONCEPTUALISE, ASSESS AND ACT ON DISEASE ACTIVITY AND PROGRESSION IN MULTIPLE SCLEROSIS: A REAL-WORLD MULTI-COUNTRY SURVEY
Aug 11, 2026, 17:16 PM -
DIRECT HEALTHCARE COST BURDEN OF POST-STROKE SPASTICITY IN GREECE
Aug 11, 2026, 17:16 PM -
COMPARATIVE EFFICACY OF BUDESONIDE/GLYCOPYRRONIUM/FORMOTEROL FUMARATE VERSUS BECLOMETHASONE DIPROPIONATE/GLYCOPYRRONIUM/FORMOTEROL FUMARATE IN UNCONTROLLED ASTHMA: A MATCHING ADJUSTED INDIRECT COMPARISON (MAIC)
Aug 11, 2026, 17:16 PM -
BENCHMARKING IMPOWER133 AND EXTENDING EVIDENCE TO ECOG PS2 PATIENTS USING A REGISTRY-BASED TARGET TRIAL EMULATION
Aug 11, 2026, 17:16 PM -
AI-DRIVEN ISPOR-SMDM VALIDATION OF AN EXCEL-BASED COST-EFFECTIVENESS MODEL
Aug 11, 2026, 17:16 PM -
THE CURRENT STATUS OF SOCIAL CARE-RELATED QUALITY OF LIFE FOR PEOPLE WITH DISABILITIES IN JAPAN
Aug 11, 2026, 17:16 PM -
CONTRAST-ENHANCED MAMMOGRAPHY (CEM)
Aug 11, 2026, 17:16 PM
